Protective role of protein C inhibitor in monocrotaline‐induced pulmonary hypertension
Open Access
- 24 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (11) , 2331-2339
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Overexpression of the 5-Hydroxytryptamine Transporter GeneCirculation, 2004
- Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditionsJournal of Thrombosis and Haemostasis, 2004
- Endothelial Dysfunction in Pulmonary HypertensionCirculation, 2004
- Heme Oxygenase-1 Reduces Murine Monocrotaline-Induced Pulmonary Inflammatory Responses and Resultant Right Ventricular OverloadAntioxidants & Redox Signaling, 2002
- The role of thrombosis in severe pulmonary hypertensionEuropean Respiratory Journal, 1996
- Protein C inhibitor is expressed in tubular cells of human kidney.Journal of Clinical Investigation, 1994
- Lactate Dehydrogenase Activity and Isozyme Patterns in Tissues and Bronchoalveolar Lavage Fluid from Rats Treated with Monocrotaline PyrroleToxicology and Applied Pharmacology, 1994
- Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.Journal of Clinical Investigation, 1992
- Inhibition of Urokinase by Protein C-Inhibitor (PCI). Evidence for Identity of PCI and Plasminogen Activator Inhibitor 3Biological Chemistry Hoppe-Seyler, 1987
- Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985